GTC Biotherapeutics (fka GTCB)

[stockdak]

I liked this from the CC (thank you DD).
"We're working to bring these negotiations to a successful conclusion over the next few weeks."

But this not so much:
"And so if we were not able to do a partnership for ATryn commercialization development in the United States, on terms which we believe reflect the value of that product, we certainly could take that product in the hereditary-deficiency indication into the marketplace ourselves with a relatively small number of people, maybe a dozen or so people and we will keep that in our back pocket."
Double gulp!
A nice thought but they don't have the money.

The perpetual almost deal keeps me holding on to my shares and adding to my position at these prices. I added 29000 shares at 0.59 today.

Management had posited $6 million (?) from a partner for Atryn from 4Q 2007 and not delivered. I suppose that this may be the upfront amount on the table for the current deal. That amount does not solve their going concern issue (for 2008 20 million plus 6 is 26 million which is short of the needed 28 correct?). Could milestones for submission of the final BLA section this summer be included? In addition the priority review status is very important to bring a milestone for approval quicker.

My hope is that management delivers on the strong wording they put forth regarding the partnership discussions. The stand to loose much credibility if they fail.

DAK